Oxea increases its debt, Moody’s warns on leverage
German chemicals company Oxea is in the final stages of completing a cov-lite loan of about €1.1bn-equivalent, having increased the deal from a planned €1.015bn.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
